SEI Investments
SCLN

SEI Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

SEI Investments’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12
Closed – – 3548
2017
Q2 		$0 Buy
+12
New +$120 ﹤0.01% 3424
2015
Q4 		– Sell
-42,821
Closed -$297K – 2817
2015
Q3 		$297K Buy
42,821
+42,660
+26,497% +$365K ﹤0.01% 1483
2015
Q2 		$2K Sell
161
-494
-75% -$4.5K ﹤0.01% 2132
2015
Q1 		$6K Sell
655
-26
-4% -$207 ﹤0.01% 2001
2014
Q4 		$7K Buy
+681
New +$5.51K ﹤0.01% 1925

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SEI Investments's SCLN Position: Q3 2017 in Review

SEI Investments sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 12 shares.

SEI Investments first reported a position in SCLN in Q4 2014 and held it in 5 quarters. The position peaked at $297K in Q3 2015. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

  • SEI Investments reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • SEI Investments sold 12 Sciclone Pharmaceuticals Inc shares in Q3 2017.
  • SEI Investments first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
  • SEI Investments's Sciclone Pharmaceuticals Inc position peaked at $297K in Q3 2015.
  • 129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on SEI Investments's 13F filing for Q3 2017, filed 6 Nov 2017.